Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.565
Low: 1.475
Prev. Close: 1.65
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder

Wed, 22nd Apr 2020 15:13

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday, Tuesday and Wednesday and not separately reported by Alliance News:

----------

Shield Therapeutics PLC - pharmaceuticals - Tim Watts promoted to chief executive officer from chief financial officer, replacing the company's founder, Carl Sterritt. Shield said Sterritt, who formed the company in 2008, resigned "following discussions with major shareholders and with mutual agreement". Watts has been CFO since August 2018, previously having served in the same role at Oxford BioMedica PLC. Watts also worked at AstraZeneca PLC for 22 years.

----------

Bunzl PLC - distributor - Hires Vin Murria as non-executive director, starting June 1. Was founder & chief executive officer of Advanced Computer Software Group PLC. She is currently a non-executive director at Softcat PLC, DWF Group PLC and finnCap Group PLC.

----------

Mobile Streams PLC - data analytics platform - Peter Tomlinson resigns as director immediately, having been with the company for 20 years. Tomlinson stepped in as chair of Mobile Streams at the start of 2018, handing over to Nigel Burton late last year as the company raised equity following a vote by shareholders against delisting the company from AIM. Mobile Streams said Wednesday that Tomlinson "took over as chairman during a difficult time and supported the transition to a new management team".

----------

Metro Bank PLC - Gene Lockhart and Stuart Bernau step down as non-executive directors from May 18, replaced by Anne Grim, Ian Henderson, and Nicholas Winsor. Grim was chief customer officer for fund manager Fidelity International Ltd, and also worked for lenders Barclays PLC and Wells Fargo & Co. Henderson is CEO of Australian know-your-customer service provider Kyckr. Prior that he was chief operating officer for private banking businesses at Barclays Wealth and CEO of RBS International at Royal Bank of Scotland Group PLC. Winsor was CEO of several HSBC Holdings PLC businesses. Metro Bank noted its board now will consist of eight independent non-executive directors and two executive directors.

----------

Centrica PLC - Carlos Pascual and Steve Pusey will step down as non-executive directors from the annual general meeting on May 22.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

Read more
21 Jan 2021 20:12

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

Read more
19 Jan 2021 15:04

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

Read more
15 Jan 2021 13:11

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

Read more
14 Dec 2020 16:59

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Read more
11 Dec 2020 16:40

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

Read more
19 Oct 2020 17:34

IN BRIEF: Shield Therapeutics Notes Teva Withdrawing Patent Opposition

IN BRIEF: Shield Therapeutics Notes Teva Withdrawing Patent Opposition

Read more
19 Oct 2020 09:12

Shield shares rise as Teva withdraws patent oppositions

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on its opposition proceedings with Teva Pharmaceutical Industries on Monday, confirming that Teva had withdrawn its appeal and opposition over two of Shield's patents.

Read more
16 Sep 2020 11:13

Shield Therapeutics Swings To Profit As It Makes Feraccru Progress

Shield Therapeutics Swings To Profit As It Makes Feraccru Progress

Read more
7 Aug 2020 06:56

IN BRIEF: Shield Therapeutics' Product Offers Alternative For Anaemia

IN BRIEF: Shield Therapeutics' Product Offers Alternative For Anaemia

Read more
16 Jul 2020 21:19

IN BRIEF: Shield Therapeutics Notes PT20 Paper Publication

IN BRIEF: Shield Therapeutics Notes PT20 Paper Publication

Read more
26 Jun 2020 17:19

UK EXECUTIVE CHANGE SUMMARY: John Menzies Chief Executive Steps Down

UK EXECUTIVE CHANGE SUMMARY: John Menzies Chief Executive Steps Down

Read more
11 Jun 2020 16:17

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
3 Jun 2020 15:57

Shield Therapeutics shares rise on two recent research papers

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics reported the recent publication of two papers concerning its 'Feraccru' or 'Accrufer' product on Wednesday.

Read more
26 May 2020 14:22

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.